New avenues for reducing intensive care needs in patients with chronic spinal cord injury

doi:10.5492/wjccm.v5.i4.201

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5350)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

355

WORD

304

HTML

2892

Sum=3551

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

739

Download

1060

Sum=1799

Nov 4, 2016 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Crit Care Med. Nov 4, 2016; 5(4): 201-203
Published online Nov 4, 2016. doi: 10.5492/wjccm.v5.i4.201

New avenues for reducing intensive care needs in patients with chronic spinal cord injury

Pierre A Guertin

Pierre A Guertin, Department of Psychiatry and Neurosciences, Laval University, Québec City, QC G1V 0A6, Canada

Pierre A Guertin, Laval University Medical Center (CHU de Québec - CHUL), Québec City, QC G1V 4G2, Canada

Author contributions: Guertin PA solely contributed to all aspects of this editorial paper.

Conflict-of-interest statement: The author is also president and chief executive officer of Nordic Life Science Pipeline.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Correspondence to: Pierre A Guertin, PhD, Professor, Laval University Medical Center (CHU de Québec - CHUL), 2705 Laurier Boulevard, RC-9800 (Neuroscience), Québec City, QC G1V 4G2, Canada. pierre.guertin@crchul.ulaval.ca

Telephone: +1-418-5254444 Fax: +1-418-6542753

Received: March 24, 2016
Peer-review started: March 24, 2016
First decision: May 16, 2016
Revised: July 5, 2016
Accepted: August 11, 2016
Article in press: August 15, 2016
Published online: November 4, 2016

Core Tip

Core tip: This editorial is one of the first articles to describe clearly the existence of an urgent medical need for new pharmacological products aimed at providing non-invasive solutions for spinal cord injury patients suffering chronically of urinary tract infection or pneumonia. Drugs capable of activating temporarily on demand activity in specific central networks of neurons that control respiration or micturition are of particular interest.